Benitec Biopharma (BNTC) Q2 2023 Earnings

21SepConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-2.73
-1.86
-0.98
-0.11

Details

Expected EPS
N/A
Actual EPS
-2.73
Surprise EPS
-2.73
Surprise Percent
+∞%

Description

Benitec Biopharma (BNTC) has reported earnings of -2.73 per share for Q2 2023.

0 Comments

Share your thoughts